Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04053673
Title RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors , FIH, MAD Study
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ribon Therapeutics, Inc.
Age Groups: adult | senior
Covered Countries USA | ESP

No variant requirements are available.